Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett’s esophagus

Post written by Madhav Desai, MD, MPH, from the Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA. Barrett’s esophagus (BE) is a known precursor lesion for esophageal adenocarcinoma (EAC), and we know that incidence of the latter is rising in last 30 years thereby necessitating early detection and management of this …

Continue reading Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett’s esophagus

Tissue retractor system–assisted ESD of a large rectal tumor with significant fibrosis

Post written by Salmaan Jawaid, MD, from the Division of Gastroenterology, Hepatology and Nutrition, University of Florida Health, Gainesville, Florida, USA. With the assistance of a novel tissue retractor system, we successfully performed endoscopic submucosal dissection (ESD) of a large rectal lesion that had developed significant fibrosis from direct tattoo material. Typically, performing ESD of …

Continue reading Tissue retractor system–assisted ESD of a large rectal tumor with significant fibrosis

A trial comparing a 25-gauge EUS-FNA device with a 20-gauge EUS-FNB device

Post written by Priscilla A. van Riet, MD, from the Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. Our study focused on the optimization of EUS-guided tissue sampling. For this, we compared the diagnostic performance of a newly designed FNB needle, the 20G ProCore needle with a forward-facing bevel, to …

Continue reading A trial comparing a 25-gauge EUS-FNA device with a 20-gauge EUS-FNB device

Recalcitrant embedded biliary self-expanding metal stents

Post written by Marc Bernon, MB, ChB, FCS, from the Surgical Gastroenterology Unit, Division of General Surgery, University of Cape Town Health Sciences Faculty and Groote Schuur Hospital, Cape Town, South Africa. Endoscopic placement of self-expanding metal stents (SEMS) is the palliative treatment of choice for obstructive jaundice due to malignant biliary obstruction. However, a …

Continue reading Recalcitrant embedded biliary self-expanding metal stents

Editor’s Choice: Role of interventional inflammatory bowel disease in the era of biologic therapy

GIE Senior Associate Editor, Dr. John R. Saltzman, MD, highlights this article from the February issue “Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group” by Bo Shen, MD, et al.  There is an increasing recognition that Interventional (or therapeutic) inflammatory bowel disease …

Continue reading Editor’s Choice: Role of interventional inflammatory bowel disease in the era of biologic therapy

EUS-guided gastrojejunostomy for relief of gastric outlet obstruction from a large duodenal hematoma

Post written by Theodore W. James, MD, from the Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA. We present the first reported use of an EUS-guided gastrojejunostomy for the treatment of gastric outlet obstruction from a large duodenal hematoma. A 44-year-old man with a history of alcoholic pancreatitis presented …

Continue reading EUS-guided gastrojejunostomy for relief of gastric outlet obstruction from a large duodenal hematoma

Role of interventional inflammatory bowel disease in the era of biologic therapy

Post written by Bo Shen, MD, from the Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA. The team from the Global Interventional IBD (Gi-IBD) group and ASGE Special Interest Group in Interventional IBD put together a position statement on endoscopic management of structural and neoplastic complications of IBD. With better understanding of etiology, …

Continue reading Role of interventional inflammatory bowel disease in the era of biologic therapy